EdgarLookup

Inhibitor Therapeutics, Inc. — All Filings

711 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 10KSB 10KSB/A 10QSB 10QSB/A 15-12B 15-12B/A 25-NSE 3 4 4/A 424B1 424B3 5 8-A12B 8-K 8-K/A CORRESP CT ORDER D DEF 14A DEF 14C DEFR14A DEFS14A DFAN14A EFFECT NO ACT NT 10-K NT 10-Q NTN 10Q POS AM PRE 14A PRE 14C PREM14A PRER14A PRES14A REGDEX RW S-1 S-1/A S-3 S-3/A S-8 S-8 POS SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K FORM 8-K 0001193125-17-304437 Oct 5, 2017
10-Q 10-Q 0001193125-17-241706 Jul 31, 2017 Jun 30, 2017
SC 13D/A SC 13D/A 0001193125-17-238884 Jul 28, 2017
8-K FORM 8-K 0001193125-17-238688 Jul 27, 2017 Jul 25, 2017
4 FORM 4 SUBMISSION 0000899243-17-018593 Jul 19, 2017 May 4, 2017
4 FORM 4 SUBMISSION 0000899243-17-018594 Jul 19, 2017 May 4, 2017
4 FORM 4 SUBMISSION 0000899243-17-018211 Jul 12, 2017 Jun 30, 2017
8-K FORM 8-K 0001193125-17-187390 May 30, 2017
10-Q FORM 10-Q 0001193125-17-161842 May 8, 2017 Mar 31, 2017
EFFECT 9999999995-17-000932 Apr 25, 2017
POS AM POST - EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001193125-17-131083 Apr 21, 2017
4 FORM 4 SUBMISSION 0000899243-17-007153 Mar 10, 2017 Mar 8, 2017
4 FORM 4 SUBMISSION 0000899243-17-007154 Mar 10, 2017 Mar 8, 2017
4 FORM 4 SUBMISSION 0000899243-17-007152 Mar 10, 2017 Mar 8, 2017
4 FORM 4 SUBMISSION 0000899243-17-007150 Mar 10, 2017 Mar 8, 2017
4 FORM 4 SUBMISSION 0000899243-17-007151 Mar 10, 2017 Mar 8, 2017
10-K FORM 10-K 0001193125-17-048025 Feb 17, 2017 Dec 31, 2016
8-K FORM 8-K 0001193125-17-016718 Jan 24, 2017
3 PRIMARY DOCUMENT 0001509322-16-000004 Dec 6, 2016 Nov 30, 2016
DEF 14C DEFINITIVE INFORMATION STATEMENT 0001193125-16-785159 Dec 5, 2016
SC 13D/A SC 13D/A 0001144204-16-137709 Dec 2, 2016
8-K FORM 8-K 0001193125-16-784027 Dec 2, 2016 Nov 30, 2016
3 PRIMARY DOCUMENT 0001196062-16-000003 Nov 30, 2016 Nov 22, 2016
8-K FORM 8-K 0001193125-16-778249 Nov 28, 2016 Nov 22, 2016
SC 13D/A SC 13D/A 0001144204-16-136716 Nov 28, 2016
SC 13D/A SC 13D/A 0001144204-16-134827 Nov 16, 2016
4 OWNERSHIP DOCUMENT 0001144204-16-134828 Nov 15, 2016
SC 13D/A SC 13D/A 0001144204-16-132227 Nov 8, 2016
8-K FORM 8-K 0001193125-16-763097 Nov 8, 2016 Nov 2, 2016
4 OWNERSHIP DOCUMENT 0001144204-16-132226 Nov 7, 2016 Nov 4, 2016
10-Q FORM 10-Q 0001193125-16-752501 Oct 31, 2016 Sep 30, 2016
S-8 FORM S-8 0001193125-16-745087 Oct 24, 2016
10-Q FROM 10-Q 0001193125-16-680021 Aug 12, 2016 Jun 30, 2016
424B3 FINAL PROSPECTUS 0001193125-16-658145 Jul 26, 2016
EFFECT 9999999995-16-005218 Jul 22, 2016
S-1/A AMENDMENT NO. 2 TO FORM S-1 0001193125-16-652618 Jul 21, 2016
CORRESP 0001193125-16-653881 Jul 21, 2016
S-1/A AMENDMENT NO. 1 TO FORM S-1 0001193125-16-650320 Jul 18, 2016
CORRESP 0001193125-16-650335 Jul 18, 2016
4 FORM 4 SUBMISSION 0000899243-16-024609 Jul 6, 2016 Jul 1, 2016
UPLOAD 0000000000-16-083232 Jul 6, 2016
4 FORM 4 SUBMISSION 0000899243-16-024600 Jul 6, 2016 Jul 1, 2016
4 FORM 4 SUBMISSION 0000899243-16-024608 Jul 6, 2016 Jul 1, 2016
4/A FORM 4/A SUBMISSION 0000899243-16-023278 Jun 20, 2016 Jun 15, 2016
4 FORM 4 SUBMISSION 0000899243-16-023280 Jun 20, 2016 Jun 15, 2016
S-1 FORM S-1 REGISTRATION STATEMENT 0001193125-16-624692 Jun 17, 2016
4 FORM 4 SUBMISSION 0000899243-16-023203 Jun 17, 2016 Jun 15, 2016
SC 13D/A SCHEDULE 13D (AMENDMENT NO. 2) 0001571049-16-016062 Jun 16, 2016
4 FORM 4 SUBMISSION 0000899243-16-022165 Jun 8, 2016 Jun 6, 2016
8-K FORM 8-K 0001193125-16-609937 Jun 1, 2016 May 25, 2016